Haloperidol targets brain arachidonic acid signaling

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 1, 2007, Pages 314-315

  Bazinet, Richard P ^a   Bhattacharjee, Abesh K ^a   Lee, Ho Joo ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOPAMINE 2 RECEPTOR; FATTY ACID; HALOPERIDOL; PHOSPHOLIPASE A2; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ARACHIDONIC ACID METABOLISM; AUTORADIOGRAPHY; BASAL GANGLION; BRAIN; DOPAMINERGIC SYSTEM; DRUG EFFECT; FATTY ACID ANALYSIS; FATTY ACID METABOLISM; FRONTAL CORTEX; LETTER; LIMBIC SYSTEM; NEUROPHARMACOLOGY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PSYCHOPHARMACOLOGY; RAT; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; ARACHIDONIC ACID; AUTORADIOGRAPHY; BRAIN CHEMISTRY; FATTY ACIDS; HALOPERIDOL; MALE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 33845752876     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.03.038     Document Type: Letter

References (19)

1. Basselin M., Chang L., Bell J.M., and Rapoport S.I. Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid. Neuropsychopharmacology 30 6 (2005) 1064-1075
2. Bazan N.G. Lipid signaling in neural plasticity, brain repair, and neuroprotection. Mol Neurobiol 32 1 (2005) 89-103
3. Bazinet R.P., Rao J.S., Chang L., Rapoport S.I., and Lee H.J. Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat. Psychopharmacology (Berl) 182 1 (2005) 180-185
4. Bazinet R.P., Rao J.S., Chang L., Rapoport S.I., and Lee H.J. Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder. Biol Psychiatry 59 5 (2006) 401-407
5. Bhattacharjee A.K., Chang L., Lee H.J., Bazinet R.P., Seemann R., and Rapoport S.I. D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats. Psychopharmacology (Berl) 180 4 (2005) 735-742
6. Bhattacharjee A.K., Chang L., White L., Bazinet R.P., and Rapoport S.I. d-Amphetamine stimulates D(2) dopamine receptor-mediated brain signaling involving arachidonic acid in unanesthetized rats. J Cereb Blood Flow Metab (2006)
7. Chang M.C., Grange E., Rabin O., Bell J.M., Allen D.D., and Rapoport S.I. Lithium decreases turnover of arachidonate in several brain phospholipids. Neurosci Lett 220 3 (1996) 171-174
8. Chang M.C., Bell J.M., Purdon A.D., Chikhale E.G., and Grange E. Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment. Neurochem Res 24 3 (1999) 399-406
9. Chang M.C., Contreras M.A., Rosenberger T.A., Rintala J.J., Bell J.M., and Rapoport S.I. Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers. J Neurochem 77 3 (2001) 796-803
10. Demar Jr. J.C., Ma K., Chang L., Bell J.M., and Rapoport S.I. alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J Neurochem 94 4 (2005) 1063-1076
11. Diau G.Y., Hsieh A.T., Sarkadi-Nagy E.A., Wijendran V., Nathanielsz P.W., and Brenna J.T. The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system. BMC Med 3 (2005) 11
12. Lands W.E.M., and Crawford C.G. In: Marinosi A. (Ed). Enzymes of membrane phospholipid metabolism (1976), Plenum, New York 3-85
13. Levant B., Crane J.F., and Carlson S.E. Sub-chronic antipsychotic drug treatment does not alter brain phospholipid fatty acid composition in rats. Prog Neuropsychopharmacol Biol Psychiatry (2006)
14. Myers C.S., Contreras M.A., Chang M.C., Rapoport S.I., and Appel N.M. Haloperidol downregulates phospholipase A(2) signaling in rat basal ganglia circuits. Brain Res 896 1-2 (2001) 96-101
15. Parikh V., Khan M.M., and Mahadik S.P. Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J Psychiatr Res 37 1 (2003) 43-51
16. Piomelli D., Pilon C., Giros B., Sokoloff P., Martres M.P., and Schwartz J.C. Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism. Nature 353 6340 (1991) 164-167
17. Rapoport S.I., Chang M.C., and Spector A.A. Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J Lipid Res 42 5 (2001) 678-685
18. Robinson P.J., Noronha J., DeGeorge J.J., Freed L.M., Nariai T., and Rapoport S.I. A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res Brain Res Rev 17 3 (1992) 187-214
19. Trzeciak H.I., Kalacinski W., Malecki A., and Kokot D. Effect of neuroleptics on phospholipase A2 activity in the brain of rats. Eur Arch Psychiatry Clin Neurosci 245 3 (1995) 179-182